|
|
||||||||
| ||||||||||||
The following table or figure may be downloaded to PowerPoint for personal use in teaching and presentations. This feature is available to all subscribers to the journal. You MUST read and follow the guidelines at Request to Reproduce AJR Content if you are distributing or using AJR content beyond academic use (limited distribution, non-revenue producing, or educational purposes). (Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Fig. 5. Probability of malignancy of hepatic lesion as function of
lesion's calculated T2 modified on basis of enhancement characteristics of
contrast medium and patient history of prior malignancy status. Thin solid
line = no primary malignancy and positive gadopentetate dimeglumine
enhancement pattern, thick solid line = primary malignancy and negative
gadopentetate dimeglumine enhancement pattern, dotted line = primary
malignancy and positive gadopentetate dimeglumine enhancement pattern, dotted
dashed line = no primary malignancy and negative gadopentetate dimeglumine
enhancement pattern.
![]()
Return to article
Hotlight (NEW!) ![]()
![]()
What's Hotlight?
HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS